IBEX Technologies Inc.
IBT
Ранг среди акций
#28813
Founded in 1972 and based in Montreal, Canada, IBEX Technologies Inc.... Founded in 1972 and based in Montreal, Canada, IBEX Technologies Inc. specializes in the production and global distribution of enzymes tailored for biomedical applications. The company's reach extends to Canada, the United States, Germany, and the United Kingdom, as well as other international markets. Its extensive product catalog features recombinant glycosaminoglycan lyases, such as Heparinase I, II, and III, along with Chondroitinase AC and B. Furthermore, IBEX offers collagen ELISAs designed to investigate the synthesis and breakdown of connective tissue components, complementing these with collagen antibodies and diamine oxidase liquid. They are also a key provider of arthritis assays, essential for research into osteoarthritis. Beyond their product lines, IBEX delivers lyophilization services for disposable medical device parts, in addition to custom fermentation and contract manufacturing capabilities. Their diverse client base encompasses medical device fabricators, quality control facilities, producers of low molecular weight heparin, and academic research institutions.
Цена акции
$1.05
Последняя синхронизация: 2024-04-11
Рыночная капитализация
$23.31M
Изменение (1 день)
-0.01%
Изменение (1 год)
5.21%
Страна
CA
Торговля IBEX Technologies Inc. (IBT)
Категория
Healthcare
Рыночная капитализация IBEX Technologies Inc.(IBT)
Рыночная капитализация: $23.31M
По состоянию на October 2026 рыночная капитализация IBEX Technologies Inc. составляет $23.31M. Согласно нашим данным, IBEX Technologies Inc. занимает 28813th место среди самых ценных компаний мира по рыночной капитализации. Рыночная капитализация — это общая рыночная стоимость всех находящихся в обращении акций публичной компании и обычно используется для оценки ее стоимости.
История рыночной капитализации IBEX Technologies Inc. с 2018 по 2026
IBT по сравнению с пятеркой самых популярных stocks
